183 related articles for article (PubMed ID: 30251836)
1. Design, Synthesis, and Evaluation of Piperazinyl Pyrrolidin-2-ones as a Novel Series of Reversible Monoacylglycerol Lipase Inhibitors.
Aida J; Fushimi M; Kusumoto T; Sugiyama H; Arimura N; Ikeda S; Sasaki M; Sogabe S; Aoyama K; Koike T
J Med Chem; 2018 Oct; 61(20):9205-9217. PubMed ID: 30251836
[TBL] [Abstract][Full Text] [Related]
2. The discovery of azetidine-piperazine di-amides as potent, selective and reversible monoacylglycerol lipase (MAGL) inhibitors.
Zhu B; Connolly PJ; Zhang YM; McDonnell ME; Bian H; Lin SC; Liu L; Zhang SP; Chevalier KM; Brandt MR; Milligan CM; Flores CM; Macielag MJ
Bioorg Med Chem Lett; 2020 Jul; 30(14):127243. PubMed ID: 32527545
[TBL] [Abstract][Full Text] [Related]
3. The discovery of diazetidinyl diamides as potent and reversible inhibitors of monoacylglycerol lipase (MAGL).
Zhu B; Connolly PJ; Zhang SP; Chevalier KM; Milligan CM; Flores CM; Macielag MJ
Bioorg Med Chem Lett; 2020 Jun; 30(12):127198. PubMed ID: 32334914
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and pharmacological evaluation of 2,4-dinitroaryldithiocarbamate derivatives as novel monoacylglycerol lipase inhibitors.
Kapanda CN; Masquelier J; Labar G; Muccioli GG; Poupaert JH; Lambert DM
J Med Chem; 2012 Jun; 55(12):5774-83. PubMed ID: 22651858
[TBL] [Abstract][Full Text] [Related]
5. Pharmacologic Characterization of JNJ-42226314, [1-(4-Fluorophenyl)indol-5-yl]-[3-[4-(thiazole-2-carbonyl)piperazin-1-yl]azetidin-1-yl]methanone, a Reversible, Selective, and Potent Monoacylglycerol Lipase Inhibitor.
Wyatt RM; Fraser I; Welty N; Lord B; Wennerholm M; Sutton S; Ameriks MK; Dugovic C; Yun S; White A; Nguyen L; Koudriakova T; Tian G; Suarez J; Szewczuk L; Bonnette W; Ahn K; Ghosh B; Flores CM; Connolly PJ; Zhu B; Macielag MJ; Brandt MR; Chevalier K; Zhang SP; Lovenberg T; Bonaventure P
J Pharmacol Exp Ther; 2020 Mar; 372(3):339-353. PubMed ID: 31818916
[TBL] [Abstract][Full Text] [Related]
6. Design and Synthesis of Novel Spiro Derivatives as Potent and Reversible Monoacylglycerol Lipase (MAGL) Inhibitors: Bioisosteric Transformation from 3-Oxo-3,4-dihydro-2
Ikeda S; Sugiyama H; Tokuhara H; Murakami M; Nakamura M; Oguro Y; Aida J; Morishita N; Sogabe S; Dougan DR; Gay SC; Qin L; Arimura N; Takahashi Y; Sasaki M; Kamada Y; Aoyama K; Kimoto K; Kamata M
J Med Chem; 2021 Aug; 64(15):11014-11044. PubMed ID: 34328319
[TBL] [Abstract][Full Text] [Related]
7. Discovery of novel reversible monoacylglycerol lipase inhibitors via docking-based virtual screening.
Xiong F; Ding X; Zhang H; Luo X; Chen K; Jiang H; Luo C; Xu H
Bioorg Med Chem Lett; 2021 Jun; 41():127986. PubMed ID: 33766770
[TBL] [Abstract][Full Text] [Related]
8. Design, Synthesis, and Evaluation of Reversible and Irreversible Monoacylglycerol Lipase Positron Emission Tomography (PET) Tracers Using a "Tail Switching" Strategy on a Piperazinyl Azetidine Skeleton.
Chen Z; Mori W; Deng X; Cheng R; Ogasawara D; Zhang G; Schafroth MA; Dahl K; Fu H; Hatori A; Shao T; Zhang Y; Yamasaki T; Zhang X; Rong J; Yu Q; Hu K; Fujinaga M; Xie L; Kumata K; Gou Y; Chen J; Gu S; Bao L; Wang L; Collier TL; Vasdev N; Shao Y; Ma JA; Cravatt BF; Fowler C; Josephson L; Zhang MR; Liang SH
J Med Chem; 2019 Apr; 62(7):3336-3353. PubMed ID: 30829483
[TBL] [Abstract][Full Text] [Related]
9. Discovery of Monoacylglycerol Lipase (MAGL) Inhibitors Based on a Pharmacophore-Guided Virtual Screening Study.
Jha V; Biagi M; Spinelli V; Di Stefano M; Macchia M; Minutolo F; Granchi C; Poli G; Tuccinardi T
Molecules; 2020 Dec; 26(1):. PubMed ID: 33375358
[TBL] [Abstract][Full Text] [Related]
10. Discovery of long-chain salicylketoxime derivatives as monoacylglycerol lipase (MAGL) inhibitors.
Bononi G; Granchi C; Lapillo M; Giannotti M; Nieri D; Fortunato S; Boustani ME; Caligiuri I; Poli G; Carlson KE; Kim SH; Macchia M; Martinelli A; Rizzolio F; Chicca A; Katzenellenbogen JA; Minutolo F; Tuccinardi T
Eur J Med Chem; 2018 Sep; 157():817-836. PubMed ID: 30144699
[TBL] [Abstract][Full Text] [Related]
11. Discovery of 1,5-Diphenylpyrazole-3-Carboxamide Derivatives as Potent, Reversible, and Selective Monoacylglycerol Lipase (MAGL) Inhibitors.
Aghazadeh Tabrizi M; Baraldi PG; Baraldi S; Ruggiero E; De Stefano L; Rizzolio F; Di Cesare Mannelli L; Ghelardini C; Chicca A; Lapillo M; Gertsch J; Manera C; Macchia M; Martinelli A; Granchi C; Minutolo F; Tuccinardi T
J Med Chem; 2018 Feb; 61(3):1340-1354. PubMed ID: 29309142
[TBL] [Abstract][Full Text] [Related]
12. Piperazine and piperidine carboxamides and carbamates as inhibitors of fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL).
Korhonen J; Kuusisto A; van Bruchem J; Patel JZ; Laitinen T; Navia-Paldanius D; Laitinen JT; Savinainen JR; Parkkari T; Nevalainen TJ
Bioorg Med Chem; 2014 Dec; 22(23):6694-6705. PubMed ID: 25282655
[TBL] [Abstract][Full Text] [Related]
13. Monoacylglycerol lipase (MAGL) as a promising therapeutic target.
Gil-Ordóñez A; Martín-Fontecha M; Ortega-Gutiérrez S; López-Rodríguez ML
Biochem Pharmacol; 2018 Nov; 157():18-32. PubMed ID: 30059673
[TBL] [Abstract][Full Text] [Related]
14. Azetidine and Piperidine Carbamates as Efficient, Covalent Inhibitors of Monoacylglycerol Lipase.
Butler CR; Beck EM; Harris A; Huang Z; McAllister LA; Am Ende CW; Fennell K; Foley TL; Fonseca K; Hawrylik SJ; Johnson DS; Knafels JD; Mente S; Noell GS; Pandit J; Phillips TB; Piro JR; Rogers BN; Samad TA; Wang J; Wan S; Brodney MA
J Med Chem; 2017 Dec; 60(23):9860-9873. PubMed ID: 29148769
[TBL] [Abstract][Full Text] [Related]
15. The design, synthesis and biological evaluation of novel URB602 analogues as potential monoacylglycerol lipase inhibitors.
Szabo M; Agostino M; Malone DT; Yuriev E; Capuano B
Bioorg Med Chem Lett; 2011 Nov; 21(22):6782-7. PubMed ID: 21982493
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and biological evaluation of second-generation benzoylpiperidine derivatives as reversible monoacylglycerol lipase (MAGL) inhibitors.
Granchi C; Bononi G; Ferrisi R; Gori E; Mantini G; Glasmacher S; Poli G; Palazzolo S; Caligiuri I; Rizzolio F; Canzonieri V; Perin T; Gertsch J; Sodi A; Giovannetti E; Macchia M; Minutolo F; Tuccinardi T; Chicca A
Eur J Med Chem; 2021 Jan; 209():112857. PubMed ID: 33045662
[TBL] [Abstract][Full Text] [Related]
17. Optimization of a Benzoylpiperidine Class Identifies a Highly Potent and Selective Reversible Monoacylglycerol Lipase (MAGL) Inhibitor.
Granchi C; Lapillo M; Glasmacher S; Bononi G; Licari C; Poli G; El Boustani M; Caligiuri I; Rizzolio F; Gertsch J; Macchia M; Minutolo F; Tuccinardi T; Chicca A
J Med Chem; 2019 Feb; 62(4):1932-1958. PubMed ID: 30715876
[TBL] [Abstract][Full Text] [Related]
18. Comparative biochemical characterization of the monoacylglycerol lipase inhibitor KML29 in brain, spinal cord, liver, spleen, fat and muscle tissue.
Pasquarelli N; Porazik C; Hanselmann J; Weydt P; Ferger B; Witting A
Neuropharmacology; 2015 Apr; 91():148-56. PubMed ID: 25497453
[TBL] [Abstract][Full Text] [Related]
19. A patent review of Monoacylglycerol Lipase (MAGL) inhibitors (2013-2017).
Granchi C; Caligiuri I; Minutolo F; Rizzolio F; Tuccinardi T
Expert Opin Ther Pat; 2017 Dec; 27(12):1341-1351. PubMed ID: 29053063
[TBL] [Abstract][Full Text] [Related]
20. The medicinal chemistry of agents targeting monoacylglycerol lipase.
Viso A; Cisneros JA; Ortega-Gutiérrez S
Curr Top Med Chem; 2008; 8(3):231-46. PubMed ID: 18289090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
